par admin | Mar 28, 2022 | Non classé
Potential of iPSC-derived Mesenchymal stem cells for therapy of COVID-19-associated organ failure reported by INSERM 1310 read the article here : https://pubmed.ncbi.nlm.nih.gov/33237619/
par admin | Mar 28, 2022 | Non classé
CITHERA and INSERM U1310 are part of the Horizon Europe call: HORIZON-HLTH-TOOL-2021-06- 02: Next generation advanced therapies to treat prevalent and high burden diseases with unmet needs
par admin | Mar 28, 2022 | Non classé
After evaluation by the INSERM scientific committee CSS2 (Cancer), INSERM U935 has been renewed as a monothematic Inserm Unit UMRS 1310 under the direction of Pr. Ali Turhan. The Unit, in close collaboration with CITHERA is developing cancer and leukemia models for...
par admin | Mar 28, 2022 | Non classé
CiTHERA, lauréat du Grand Défi « Biomédicaments » du gouvernement, dans le cadre de son projet SOFTCELL. Découvrez l’article ici...
par admin | Fév 24, 2022 | Non classé
New label for INSERM U935 /UA9: After evaluation by the INSERM scientific committee CSS2 (Cancer), INSERM U935 has been renewed as a monothematic Inserm Unit UMRS 1310 under the direction of Pr. Ali Turhan. The Unit, in close collaboration with CITHERA is developing...
Commentaires récents